Liraglutide effects in a paediatric (7‐11 y) population with obesity: A randomized, double‐blind, placebo‐controlled, short‐term trial to assess safety, tolerability, pharmacokinetics, and pharmacodynamics

BACKGROUND: Childhood obesity is a major public health concern with limited treatment options. OBJECTIVE: The aim of this study was to assess safety, tolerability, pharmacokinetics, and pharmacodynamics during short‐term treatment with liraglutide in children (7‐11 y) with obesity. METHODS: In this...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pediatr Obes
Autors principals: Mastrandrea, Lucy D., Witten, Louise, Carlsson Petri, Kristin C., Hale, Paula M., Hedman, Hanna K., Riesenberg, Robert A.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6590663/
https://ncbi.nlm.nih.gov/pubmed/30653847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijpo.12495
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars